Recorded live at HFSA 2025, hosts explore the evolving landscape of heart failure endpoints, focusing on the significance of oral diuretic intensification in outpatient care.
All content for Don't Miss a Beat is the property of HCPLive Cardiology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Recorded live at HFSA 2025, hosts explore the evolving landscape of heart failure endpoints, focusing on the significance of oral diuretic intensification in outpatient care.
SURPASS-CVOT and Tirzepatide, a Dual GIP/GLP-1 RA, in ASCVD
Don't Miss a Beat
24 minutes
3 months ago
SURPASS-CVOT and Tirzepatide, a Dual GIP/GLP-1 RA, in ASCVD
Don't Miss a Beat
Recorded live at HFSA 2025, hosts explore the evolving landscape of heart failure endpoints, focusing on the significance of oral diuretic intensification in outpatient care.
